Herbal remedies for depression and anxiety

Depression and anxiety disorders are among the most prevalent neuropsychiatric conditions worldwide, significantly affecting quality of life and increasing the global disease burden. Conventional pharmacotherapy, including selective serotonin reuptake inhibitors (SSRIs) and benzodiazepines, is often associated with delayed onset of action, adverse effects, and risk of dependency. These limitations have led to growing interest in herbal remedies as alternative or complementary therapeutic options. This review explores the pharmacological potential of medicinal plants in the management of depression and anxiety, emphasizing their bioactive constituents and mechanisms of action. Key herbal agents such as Hypericum perforatum (St. John’s Wort), Withania somnifera (Ashwagandha), Bacopa monnieri (Brahmi), Valeriana officinalis (Valerian), and Passiflora incarnata (Passionflower) are discussed in detail. These plants exhibit neuroprotective, anxiolytic, and antidepressant effects through modulation of neurotransmitters, including serotonin, dopamine, and gamma-aminobutyric acid (GABA), as well as through antioxidant and anti-inflammatory pathways. The review also addresses clinical evidence, safety profiles, herb-drug interactions, and challenges associated with standardization and regulatory approval. Despite promising preclinical and clinical findings, variability in phytochemical composition and lack of large-scale clinical trials remain significant limitations. Future perspectives highlight the integration of nanotechnology-based drug delivery systems, personalized herbal medicine, and advanced analytical techniques for improved efficacy and reproducibility. Herbal remedies hold substantial promise as safer and effective alternatives for managing depression and anxiety, provided that rigorous scientific validation and standardization are achieved